Davis L. Temple

Statistics

Publications

Citations

846

H-Index

Active since

1970

Affiliations

Bristol-Myers Squibb (United States)(Current)

CNS Research (United States)

Davis L. Temple is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, pharmacology, and structure-activity relationships.

Publications per year

1970–2010

Publications

Oxazolines. XI. Synthesis of functionalized aromatic and aliphatic acids. Useful protecting group for carboxylic acids against Grignard and hydride reagents

A. I. MEYERS, Davis L. Temple, Dan Haidukewych et al. · The Journal of Organic Chemistry · 1974 · 145 citations

Natural Sciences, Chemistry, Medicinal Chemistry +14

Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)- and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents

Joseph P. Yevich, James S. New, David W. Smith et al. · Journal of Medicinal Chemistry · 1986 · 114 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Oxazolines. IX. Synthesis of homologated acetic acids and esters

A. I. MEYERS, Davis L. Temple, R. L. Nolen et al. · The Journal of Organic Chemistry · 1974 · 91 citations

Natural Sciences, Chemistry, Medicinal Chemistry +9

Neuropharmacology of Buspirone

L.A. Riblet, Arlene S. Eison, Michael S. Eison et al. · Psychopathology · 2010 · 80 citations

Medicine, Neuroscience, Pharmacology +17

Syntheses via 2-oxazolines. II. Versatile synthesis of aliphatic carboxylic acids and esters. Mono-and dialkylation of acids masked by a simple protecting group

A. I. MEYERS, Davis L. Temple · Journal of the American Chemical Society · 1970 · 60 citations

Natural Sciences, Chemistry, Medicinal Chemistry +13

1–5 of 17